Skip to main content

TFF Pharmaceuticals, Inc.

TFFPDelisted Mar 6, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001733413

TFF Pharmaceuticals, Inc. was delisted on Mar 6, 2025; its insiders filed their last Form 4 on Jul 8, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $1.48M in total; no superinvestor held it.

13F holders, Q4 2022

Institutional positions in TFF Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
41
−3 vs. Q3 2022
Shares held
7.23M
+4.00M (+123.7%) vs. Q3 2022
Total value
$7.52M
−$5.59M (−42.6%) vs. Q3 2022
New holders
10
8 more added
Sold out
13
12 more reduced

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TFFP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 41 institutions
Q1 2021: 63 institutionsQ2 2021: 60 institutionsQ3 2021: 54 institutionsQ4 2021: 51 institutionsQ1 2022: 43 institutionsQ2 2022: 45 institutionsQ3 2022: 45 institutionsQ4 2022: 41 institutionsQ1 2023: 36 institutionsQ2 2023: 33 institutionsQ3 2023: 41 institutionsQ4 2023: 23 institutionsQ1 2024: 19 institutionsQ2 2024: 21 institutionsQ3 2024: 23 institutionsQ4 2024: 4 institutionsQ1 2025: 3 institutionsQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ4 2022: $7.52M
Q1 2021: $96.1MQ2 2021: $54.5MQ3 2021: $45.1MQ4 2021: $41.1MQ1 2022: $27.1MQ2 2022: $23.7MQ3 2022: $17.2MQ4 2022: $7.52MQ1 2023: $4.80MQ2 2023: $3.02MQ3 2023: $4.04MQ4 2023: $2.45MQ1 2024: $2.12MQ2 2024: $1.07MQ3 2024: $1.48MQ4 2024: $196Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding TFFP and their total value by quarter
QuarterHoldersValue
Q2 20261$0
Q1 20261$0
Q4 20251$0
Q3 20251$0
Q2 20251$0
Q1 20253$0
Q4 20244$196
Q3 202423$1.48M
Q2 202421$1.07M
Q1 202419$2.12M
Q4 202323$2.45M
Q3 202341$4.04M
Q2 202333$3.02M
Q1 202336$4.80M
Q4 202241$7.52M
Q3 202245$17.2M
Q2 202245$23.7M
Q1 202243$27.1M
Q4 202151$41.1M
Q3 202154$45.1M
Q2 202160$54.5M
Q1 202163$96.1M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding TFF Pharmaceuticals, Inc.; share changes are against Q3 2022.

Institutions holding TFFP in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
AIGH Capital Management LLC1,739,130$1.83M0.60%+1,739,130New
Carlson Capital L P1,242,000$1.30M0.10%+967,000+351.6%Added
DRW Securities, LLC1,000,000$1.05M0.21%+1,000,000New
Vanguard Group Inc859,449$902.4K0.00%−8,982−1.0%Reduced
Worth Venture Partners, LLC427,824$449.2K0.27%+427,824New
Sepio Capital, LP330,600$347.1K0.03%+15,540+4.9%Added
BlackRock Inc.259,790$272.8K0.00%+654+0.3%Added
Millennium Management LLC190,047$200.0K0.00%+190,047New
Geode Capital Management, LLC187,878$197.0K0.00%−456−0.2%Reduced
UBS Group AG114,071$119.8K0.00%+16,462+16.9%Added
Princeton Capital Management LLC101,449$106.5K0.05%−35,125−25.7%Reduced
Sigma Planning Corp100,891$105.9K0.00%+24,000+31.2%Added
Renaissance Technologies LLC72,155$76.0K0.00%+72,155New
State Street Corp69,929$73.4K0.00%00.0%Unchanged
Bridgeway Capital Management, LLC58,700$61.6K0.00%00.0%Unchanged
Two Sigma Investments, LP56,954$59.8K0.00%+56,954New
Westside Investment Management, Inc.50,725$53.0K0.00%−1,250−2.4%Reduced
Citadel Advisors LLC46,052$48.4K0.00%−8,213−15.1%Reduced
Northern Trust Corp39,108$41.1K0.00%00.0%Unchanged
Fermata Advisors, LLC28,547$30.0K0.01%+743+2.7%Added
Susquehanna International Group, LLP24,150$25.4K0.00%−42,361−63.7%Reduced
University of Texas/Texas Am Investment Managment Co22,066$23.0K0.01%00.0%Unchanged
Stifel Financial Corp19,700$20.7K0.00%−4,500−18.6%Reduced
Price T Rowe Associates Inc16,700$18.0K0.00%−6,000−26.4%Reduced
Virtu Financial LLC12,532$13.0K0.00%−8,244−39.7%Reduced
CI Private Wealth, LLC12,000$12.6K0.00%+12,000New
StoneX Group Inc.11,382$12.0K0.00%+11,382New
Quantum Private Wealth, LLC11,082$11.6K0.01%00.0%Unchanged
Jane Street Group, LLC10,761$11.3K0.00%+10,761New
Baldwin Brothers Inc10,000$10.5K0.00%00.0%Unchanged
Thompson Davis & Co., Inc.10,000$10.5K0.01%+10,000New
Morgan Stanley8,056$8.46K0.00%+6,033+298.2%Added
Newbridge Financial Services Group, Inc.5,000$5.25K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)4,718$5.00K0.00%+300+6.8%Added
Bank of America Corp3,462$3.64K0.00%−145−4.0%Reduced
Parallel Advisors, LLC2,963$3.11K0.00%00.0%Unchanged
Wells Fargo & Company2,672$2.81K0.00%−26,422−90.8%Reduced
HM Payson & Co1,500$1.57K0.00%00.0%Unchanged
Cutler Group LP1,000$1.00K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.1,000$1.00K0.00%00.0%Unchanged
Gagnon Securities LLC62,264––−222,566−78.1%Reduced
Raymond James & Associates0$00.00%−47,450−100.0%Sold out
Mesirow Financial Investment Management, Inc.0$00.00%−40,013−100.0%Sold out
National Asset Management, Inc.0$00.00%−27,800−100.0%Sold out
Sanders Morris Harris LLC0$00.00%−20,826−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−19,663−100.0%Sold out
Charles Schwab Investment Management Inc0$00.00%−11,966−100.0%Sold out
Meridian Wealth Advisors, LLC0$00.00%−11,500−100.0%Sold out
Venturi Wealth Management, LLC0$00.00%−8,273−100.0%Sold out
Caption Management, LLC0$00.00%−5,000−100.0%Sold out
Simplex Trading, LLC0$00.00%−3,213−100.0%Sold out
Selective Wealth Management, Inc.0$00.00%−3,200−100.0%Sold out
Royal Bank of Canada0$00.00%−614−100.0%Sold out
Steward Partners Investment Advisory, LLC0$00.00%−100−100.0%Sold out
DRW Securities, L.L.C.––––Not filed